Birzele F - Search Results

1

Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical In Vivo Models: Identification of Targets and New Modalities for Therapeutic Intervention.

Weidle UH, Birzele F. Weidle UH, et al. Among authors: birzele f. Cancer Genomics Proteomics. 2024 Apr 26;21(3):213-237. doi: 10.21873/cgp.20442. Cancer Genomics Proteomics. 2024. PMID: 38670587 Free PMC article. Review.

2

Circular RNA in Non-small Cell Lung Carcinoma: Identification of Targets and New Treatment Modalities.

Weidle UH, Birzele F. Weidle UH, et al. Among authors: birzele f. Cancer Genomics Proteomics. 2023 Dec;20(6suppl):646-668. doi: 10.21873/cgp.20413. Cancer Genomics Proteomics. 2023. PMID: 38035705 Free PMC article. Review.

3

Perspectives of data science in preclinical safety assessment.

Steger-Hartmann T, Kreuchwig A, Wang K, Birzele F, Draganov D, Gaudio S, Rothfuss A. Steger-Hartmann T, et al. Among authors: birzele f. Drug Discov Today. 2023 Aug;28(8):103642. doi: 10.1016/j.drudis.2023.103642. Epub 2023 May 26. Drug Discov Today. 2023. PMID: 37244565 Review.

4

Triple-negative Breast Cancer: Identification of circRNAs With Efficacy in Preclinical In Vivo Models.

Weidle UH, Birzele F. Weidle UH, et al. Among authors: birzele f. Cancer Genomics Proteomics. 2023 Mar-Apr;20(2):117-131. doi: 10.21873/cgp.20368. Cancer Genomics Proteomics. 2023. PMID: 36870692 Free PMC article. Review.

5

Long Non-coding RNAs With In Vitro and In Vivo Efficacy in Preclinical Models of Esophageal Squamous Cell Carcinoma Which Act by a Non-microRNA Sponging Mechanism.

Weidle UH, Birzele F. Weidle UH, et al. Among authors: birzele f. Cancer Genomics Proteomics. 2022 Jul-Aug;19(4):372-389. doi: 10.21873/cgp.20327. Cancer Genomics Proteomics. 2022. PMID: 35732324 Free PMC article. Review.

6

In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti-PD-1/PD-L1 Therapies.

Denis M, Grasselly C, Choffour PA, Wierinckx A, Mathé D, Chettab K, Tourette A, Talhi N, Bourguignon A, Birzele F, Kress E, Jordheim LP, Klein C, Matera EL, Dumontet C. Denis M, et al. Among authors: birzele f. Cancer Immunol Res. 2022 Aug 3;10(8):1013-1027. doi: 10.1158/2326-6066.CIR-21-0802. Cancer Immunol Res. 2022. PMID: 35679518

7

Bladder Cancer-related microRNAs With In Vivo Efficacy in Preclinical Models.

Weidle UH, Birzele F. Weidle UH, et al. Among authors: birzele f. Cancer Diagn Progn. 2021 Jul 3;1(4):245-263. doi: 10.21873/cdp.10033. eCollection 2021 Sep-Oct. Cancer Diagn Progn. 2021. PMID: 35403137 Free PMC article. Review.

8

Down-regulated MicroRNAs in Gastric Carcinoma May Be Targets for Therapeutic Intervention and Replacement Therapy.

Weidle UH, Birzele F, Auslaender S, Brinkmann U. Weidle UH, et al. Among authors: birzele f. Anticancer Res. 2021 Sep;41(9):4185-4202. doi: 10.21873/anticanres.15223. Epub 2021 Sep 1. Anticancer Res. 2021. PMID: 34475038 Review.

9

Gastric Cancer: Identification of microRNAs Inhibiting Druggable Targets and Mediating Efficacy in Preclinical In Vivo Models.

Weidle UH, Birzele F, Brinkmann U, Auslaender S. Weidle UH, et al. Among authors: birzele f. Cancer Genomics Proteomics. 2021 Jul-Aug;18(4):497-514. doi: 10.21873/cgp.20275. Cancer Genomics Proteomics. 2021. PMID: 34183383 Free PMC article. Review.

10

microRNAs Promoting Growth of Gastric Cancer Xenografts and Correlation to Clinical Prognosis.

Weidle UH, Birzele F, Nopora A. Weidle UH, et al. Among authors: birzele f. Cancer Genomics Proteomics. 2021 Jan-Feb;18(1):1-15. doi: 10.21873/cgp.20237. Epub 2021 Jan 8. Cancer Genomics Proteomics. 2021. PMID: 33419892 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page